Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Clinical determinants of survival outcomes and acute toxicity after adoptive cellular therapy for solid tumors.
Journal: Frontiers in immunology
Published: April 06, 2026
Bispecific Antibodies in Solid Tumors: Mechanistic Insights, Clinical Advances, and Future Directions.
Journal: Journal of immunotherapy and precision oncology
Published: November 26, 2025
Telemedicine as a gateway to early-phase oncology trials: lessons from 14 000 patients and future directions for global access and equity.
Journal: The oncologist
Published: September 30, 2025
Therapeutic responses in patients with advanced NSCLC enrolled in early-phase clinical trials at MD Anderson.
Journal: NPJ precision oncology
Published: September 09, 2025
Modulating Treatment Outcomes of Patients with Solid Tumors in Immunotherapy Trials: A Drug Interaction Analysis from a Phase I Unit.
Journal: Cancer research communications
Published: February 04, 2025
Methylthioadenosine Phosphorylase Genomic Loss in Advanced Gastrointestinal Cancers.
Journal: The oncologist
Published: July 10, 2023
Comparative Genomic Analysis and Clinical Outcomes of BRAF-mutated Advanced Biliary Tract Cancers.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 05, 2023
Case Report: Durable Response to Very Low Dose Tyrosine Kinase Inhibitors in Advanced Hepatocellular Carcinoma.
Journal: Frontiers in oncology
Published: September 21, 2021
Associations of Racial and Ethnic Category, Age, Comorbidities, and Socioeconomic Factors on Concordance to NCCN Guidelines for Patients With High-Risk Biliary Tract Cancers After Surgery.
Journal: Frontiers in oncology
Published: September 06, 2021
Idiopathic chronic pancreatitis treated with ivacaftor in a CFTR carrier with methylmalonic acidemia.
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: April 25, 2021
Adoption of single agent anticancer therapy for advanced hepatocellular carcinoma and impact of facility type, insurance status, and income on survival: Analysis of the national cancer database 2004-2014.
Journal: Cancer medicine
Published: October 23, 2020
Showing 1-12 of 12
Last Updated: 09/26/2026